Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
P4-ATPases, also known as phospholipid-transporting ATPases, are a subfamily of P-type ATPases that function as lipid flippases.[2][3][5] These enzymes hydrolyze ATP to transport specific phospholipids from the outer to the inner leaflet of eukaryotic cell membranes, maintaining membrane lipid asymmetry, which is essential for various cellular processes including vesicle formation, trafficking, signal transduction, and apoptotic signaling.[2][3][5] P4-ATPases are highly conserved across eukaryotes and in humans comprise at least 14 distinct isoforms.[2] Defects in P4-ATPases have been associated with disorders such as progressive familial intrahepatic cholestasis (PFIC, due to ATP8B1 mutations) and certain neurological syndromes.[3] Recent studies suggest they may represent new therapeutic targets against infectious agents and multidrug-resistance phenotypes, with small-molecule inhibitors under study for such uses.[1] \n\nStructural features include three cytoplasmic domains (actuator, nucleotide-binding, and phosphorylation) and a membrane domain with multiple transmembrane helices.[1][2][3] The catalytic mechanism (Post-Albers cycle) involves sequential phosphorylation and dephosphorylation, driving conformational changes that facilitate lipid substrate translocation.[2][4][5].\n\nIn summary, P4-ATPases are crucial enzymes for maintaining membrane phospholipid distribution, with significant implications in human physiology and disease.
ATP-driven translocation ("flipping") of specific phospholipids from the exoplasmic/luminal leaflet to the cytoplasmic leaflet of membranes\nDisruption of this activity may lead to defects in lipid asymmetry, cell signaling, and membrane integrity
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on P4-ATPase (Phospholipid-transporting ATPase) (P4-ATPase).